Beautifully engraved certificate from the G.D. Searle & Company issued in 1976. This historic document was printed by the American Banknote Company and has an ornate border around it with a vignette of an allegorical woman sitting infront of a globe. This item has the printed signatures of the Company's President, (D. C. Searle) and Secretary and is over 25 years old.
Pharmacia Corporation is a first-tier global pharmaceutical company with an industry-leading growth rate, a robust product portfolio, a high-potential research and development pipeline, and a dynamic agricultural subsidiary in Monsanto Company. Pharmacia Corporation was created in April 2000 through the merger of Pharmacia & Upjohn with Monsanto Company and its G.D. Searle unit. Pharmacia employs 59,000 people worldwide and has research, manufacturing and administrative sales operations in more than 60 countries. Pharmacia is implementing a new, comprehensive system for managing environmental, safety and health (ESH) issues and has adopted a series of ESH standards to guide operations worldwide. These are described in a detailed Environment, Safety and Health Report that includes the corporate ESH policy, discussions of the company's approach to some significant issues, stories about successful ESH initiatives at the local level and a detailed accounting of Pharmacia waste generation and waste management worldwide. Pharmacia is one of the fastest-growing competitors in the global pharmaceutical industry. In our core prescription pharmaceuticals business, we are recognized as an innovative leader in a number of therapeutic areas, including arthritis/inflammation, pain management, antibiotics, oncology and ophthalmology. They also have a strong position in a number of related businesses, including consumer healthcare, animal health, pharmaceutical commercial services (fine chemicals and global contract manufacturing) and diagnostics (US and worldwide). Their focus on Customer relationships extends to our 85 percent owned agricultural subsidiary, Monsanto Company. Monsanto's unique combination of agricultural products and unparalleled resources in plant biotechnology offers to customers innovative solutions to improve farm productivity and to reduce the costs and risks of farming. 2001 Pharmacia completes spin-off of research activities into Swedish-based Biovitrum AB 2001 Pharmacia announced collaboration with Celltech Group plc to develop CDP-870 2000 Initial Public Offering (IPO) of the Monsanto agricultural business is completed 2000 ZYVOX is launched April 3, 2000 Pharmacia Corporation is established and based in Peapack, New Jersey 1999 Monsanto and Pharmacia & Upjohn announce merger agreement 1999 Pharmacia & Upjohn acquires SUGEN, Inc. 1999 CELEBREX is launched 1999 Pharmacia & Upjohn establishes world headquarters in Somerset County, New Jersey 1997 Monsanto spins off chemical businesses as Solutia Inc. 1997 DETRUSITOL is launched 1996 XALATAN and CAMPTOSAR are launched 1995 Pharmacia & Upjohn created through merger of Pharmacia AB and The Upjohn Company 1993 Pharmacia AB created through the merger of Kabi Pharmacia and Carlo Erba 1990 Pharmacia and Kabi Vitrum merge to create Kabi Pharmacia 1987 GENOTROPIN is launched 1986 The Upjohn Company marks the 100th anniversary of its founding 1985 Monsanto acquires G.D. Searle & Company 1976 ROUNDUP herbicide is launched 1941 Searle establishes headquarters in Skokie, Illinois 1931 Kabi Vitrum established in Sweden 1911 Pharmacia established in Sweden 1908 G.D. Searle & Company is incorporated in Chicago 1901 Monsanto Chemical Works is founded by John Queeny in St. Louis, Missouri 1888 G.D. Searle & Company is founded by Gideon D. Searle in Omaha, Nebraska 1886 The Upjohn Company is founded by W.E. Upjohn in Kalamazoo, Michigan 1853 Carlo Erba company founded in Italy by pharmacist Carlo Erba